By 2032, Eli Lilly will constitute a “league of its own” in worldwide pharma sales, according to researcher Evaluate’s Annual World Preview Report, released June 23. Lilly’s expected global sales of $137 billion in 2032 will be almost 60% more than that of the second largest pharma firm, AbbVie, Evaluate reports. The overwhelming success will be driven by Lilly’s weight-loss trio, with Mounjaro at # 1 in sales of all drugs, Zepbound at #3 and Foundayo (its new pill) at #4, according to Evaluate’s forecasts. Mounjaro and Zepbound together will be worth more than $70 billion, making their common ingredient -- tirzepatide -- into “the biggest drug ever," surpassing Pfizer/BioNTech’s COVID-19 vaccines, Evaluate said. The three weight loss drugs together “will make up nearly half of total 2032 sales of the top ten best-selling drugs,” per the report.

Earlier this month, Amazon announced that Prime Day will run June 23 through June 26, marking the second year in a row that the company has expanded the event beyond its traditional two-day format. The sale arrives after a turbulent spring for many merchants, who grappled with a series of Amazon policy changes, new fees and concerns about cash flow. But unlike last year, when tariff uncertainty dominated conversations among sellers, many brands say they now have a clearer picture of their costs heading into one of Amazon’s biggest shopping events. “People are excited for Prime Day, and people are less pessimistic about Prime Day summer than they were last year,” said Adam Wilkens, founder of Amazon consultancy Dotcom Reps, which advises around 30 merchants. Wilkens said Prime Day is “widely anticipated” among many sellers. Last year, he said, “There was a reluctance or uncertainty around tariffs that is no longer an uncertainty.”

The White House on Wednesday released its AI Action Plan, a set of proposals developed by the Trump administration to meet the United States' goal for dominance in artificial intelligence (AI). Here is what we know so far.  The 90 federal actions focus on three areas: increasing private-sector innovation, expanding AI-related infrastructure and exporting American AI. The goal is set on "winning the AI race" against global competitors like China. “The United States must also drive adoption of American AI systems, computing hardware, and standards throughout the world,” according to the document. “America currently is the global leader on data center construction, computing hardware performance, and models.”